537 related articles for article (PubMed ID: 20733117)
1. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
[TBL] [Abstract][Full Text] [Related]
2. Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: the NIH-AARP Diet and Health Study.
Lew JQ; Freedman ND; Leitzmann MF; Brinton LA; Hoover RN; Hollenbeck AR; Schatzkin A; Park Y
Am J Epidemiol; 2009 Aug; 170(3):308-17. PubMed ID: 19541857
[TBL] [Abstract][Full Text] [Related]
3. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
4. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
[TBL] [Abstract][Full Text] [Related]
5. Alcohol consumption and breast cancer risk in the Women's Health Study.
Zhang SM; Lee IM; Manson JE; Cook NR; Willett WC; Buring JE
Am J Epidemiol; 2007 Mar; 165(6):667-76. PubMed ID: 17204515
[TBL] [Abstract][Full Text] [Related]
6. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
Rosenberg LU; Magnusson C; Lindström E; Wedrén S; Hall P; Dickman PW
Breast Cancer Res; 2006; 8(1):R11. PubMed ID: 16507159
[TBL] [Abstract][Full Text] [Related]
7. Association between common risk factors and molecular subtypes in breast cancer patients.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
[TBL] [Abstract][Full Text] [Related]
8. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
9. The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age.
Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Daling JR
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1061-6. PubMed ID: 14578143
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study.
Nyante SJ; Dallal CM; Gierach GL; Park Y; Hollenbeck AR; Brinton LA
Am J Epidemiol; 2013 Aug; 178(3):359-71. PubMed ID: 23899816
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
12. Alcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristics.
Falk RT; Maas P; Schairer C; Chatterjee N; Mabie JE; Cunningham C; Buys SS; Isaacs C; Ziegler RG
Am J Epidemiol; 2014 Oct; 180(7):705-17. PubMed ID: 25150269
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.
Phipps AI; Li CI; Kerlikowske K; Barlow WE; Buist DS
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1643-54. PubMed ID: 20501751
[TBL] [Abstract][Full Text] [Related]
14. Association between selenium intake and breast cancer risk: results from the Women's Health Initiative.
Guo D; Hendryx M; Liang X; Manson JE; He K; Vitolins MZ; Li Y; Luo J
Breast Cancer Res Treat; 2020 Aug; 183(1):217-226. PubMed ID: 32607639
[TBL] [Abstract][Full Text] [Related]
15. Caffeine intake from coffee and tea and invasive breast cancer incidence among postmenopausal women in the Women's Health Initiative.
Zheng KH; Zhu K; Wactawski-Wende J; Freudenheim JL; LaMonte MJ; Hovey KM; Mu L
Int J Cancer; 2021 Dec; 149(12):2032-2044. PubMed ID: 34418085
[TBL] [Abstract][Full Text] [Related]
16. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
Farhat GN; Cummings SR; Chlebowski RT; Parimi N; Cauley JA; Rohan TE; Huang AJ; Vitolins M; Hubbell FA; Manson JE; Cochrane BB; Lane DS; Lee JS
J Natl Cancer Inst; 2011 Apr; 103(7):562-70. PubMed ID: 21330633
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.
Mullooly M; Khodr ZG; Dallal CM; Nyante SJ; Sherman ME; Falk R; Liao LM; Love J; Brinton LA; Gierach GL
Am J Epidemiol; 2017 Dec; 186(12):1329-1340. PubMed ID: 28637226
[TBL] [Abstract][Full Text] [Related]
18. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.
Touillaud MS; Thiébaut AC; Fournier A; Niravong M; Boutron-Ruault MC; Clavel-Chapelon F
J Natl Cancer Inst; 2007 Mar; 99(6):475-86. PubMed ID: 17374837
[TBL] [Abstract][Full Text] [Related]
19. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
20. Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk.
Pedersen GS; Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
Breast Cancer Res Treat; 2010 Jul; 122(1):199-210. PubMed ID: 19949857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
